RESEARCH
Danish cohort study examines KRAS mutation status and VTE risk in colorectal cancerA population-based cohort study of Danish patients with stage I-IV colorectal cancer who underwent KRAS mutation testing between 2015 and 2023 examined the association between KRAS mutation status and 1-year risk of venous thromboembolism, deep vein thrombosis, and pulmonary embolism. (Journal of Thrombosis and Haemostasis)